Sleep Flashcards
ICSD criteria for chronic insomnia
Criteria A (3)
Criteria B (8)
Criteria C
Criteria D
Criteria E
- Criteria A (primary problem is that they’re not sleeping)
- diffiicutly initiating sleep
- difficulty maintaining sleep
- waking up earlier than desired
- Criteria B (daytime symptoms)
- fatigue / malaise
- attention, concentration, or memory impairment
- impaired social / family / occupational / academic performance
- mood disturbance / irritability
- daytime sleepiess
- reduced motivation / energy / initiative
- proneness for errors / accidents
- conc erns about or dissatisfaction with sleep
- Criteria C: Symptoms cannot be explained purely by inadequate opportunity to sleep
- Criteria D: Symptoms occur at leats 3 times per week
- Criteria E: Symptoms have been present for 3 months
Benzodiazepine receptor agonists
Zolpidem
Eszopiclone : long half-life
Zaleplon: shortest half-life
Non BRZA sleep aids
(4)
Ramelton (melatonin receptor agonisit
Doxepin
Benzodiazepines
Suvorexant (dual receptor agonist)
Dosing considerations for sleep aids
Zolpidem
Eszopiclone
Zaleplon
Zolpidem: decreased dose for women and all > 65
Eszopiclone: lower dose only for those > 65
Zaleplon: none
ICSD for OSA (adult)
- 1+ of the following:
- Excessive daytime sleepiness, fatigue, or insomnia
- wakes up breaht holding, gasping, or choking
- observer reports snoring, breathing interruptions
- diagnosed with hypertension, mood disorder, cognitive dysfunction, CAD, stroke, CHF, afib, or DM II
- polysomnogrmam demonstrates 5 or more obstrucive respiratory events per hour
- OR -
1. PSG shows 15 or more predominately obstructive respiratoyr events per hour of sleep during PSG or per hour of monitoring
Risk factors for OSA (7)
- Obesity
- thick neck
- Men: >42 cm
- Women: > 38 cm
- Mallampati 3-4
- retrognathia / micrognathia
- steroid exposure
- PCOS
- HIV and antiretrovirals
Mallampati classification
Apnea / hypopnea index (AHI) ranges
Normal: <5
6-14: Mild
14-30: moderate
>30: severe
ICSD criteria for Central Sleep apnea
Category 1 (general): Category 2 (3)
- Presence of at least one of the following:
- Sleepiness
- Difficulty initiating or maintaining sleep, frequent awakenings, non-restorative sleep (insomnia stuff)
- Awakening short of breath
- snoring
- witnessed apneas
-
all of the following
- five + central apneas and/or central hyponeas per hour of sleep on PSG
- number of central sleep apneas and/or central hypopneas is >50% of total number of apneas / hypopneas (majority are not obstructive)
- absence of cheyne stokes breathing
Central vs obstructive sleep apnea on PSG
Risk factors for central sleep apnea (8)
- Congestive heart failure
- chiari malformation
- Stroke
- opioids
- A fib
- chronic renal failure
- Hypothyroidism
- high altitude
Contraindication for Servoventilation and BiPAP for Central sleep apnea
Ejection fraction < 45%
(associated with increased mortality)
What does this PSG show?
Diaphragmatic paralysis (note increased use of accessory muscles)
Circadian Rhythm sleep-wke disorders
- Delayed sleep phase
- Advanced sleep phase
- Irregular sleep-wke rhythm
- Non-24 sleep wake disorder
ICSD criteria for circadian rhythm sleep-wake disorder
Criteria A
Criteria B
Criteria C
Criteria D
- Must be > 3 months in duration and due to alteration of the circadian timing system or to a misalignment between internal circadian rhythm and the sleep-wake schedule desired or required by an individual’s physical environment or social / work schedules
- Leads to excessive sleepiness, insomnia, or both
- sleep and wake disturbances cause significant distress / impairment of health
- sleep diary / actigraphy monitoring for at least 7 days (but preferably 14) shows disruption of the circadian sleep-wake cycle
Treatment for Delayed sleep phase dosorder
- Phototherapy
- blue enriched (2500-10,000 lux for 1-2 hours in th emorning shortly after core body temparture minimum (about half an hour before typical melatonin onset time)
- avoidance of bright light in the evening and prior to CBTmin
- Melatonin 0.5 mg 13-14 hours after natural wake up time
Timeline for how to give phototherapy and melatonin for advanced versus delayed sleep phase disoders
Medications specificaclly for Non-24 patients who are blind
- Tasimelton (Melatonin receptor type 1 and type 2 agonist)
- 20 mg before bedtime at the same time every night
Treatment for Jet lag
- Melatonin 0.5 mg at bedtime on arrival (can repeat up to 4 nights)
- on eastward flights - sstay awake and avoid bright light in morning and be exposed to as much light as possible in the afternoon (“heading toward the rising sun, avoid the sunrise!)
- westward flights, attempt to stay awake while light is out and not sleep until nighttime at the destination
ICSD criteria for Narcolepsy Type 1 and Type 2
Present in both:
- daily periods of irrepressible need for sleep or daytime lapses in sleep
- MSLT < 8 minutes and 2+ sleep onset REM periods on MSLT (or one + another within 15 minutes of sleep onset on preceding nocutrunal PSG)
What makes narcolepsy Type 1
- Presence of Cataplexy
- CSF hypocretin-1 <110 pg/mL
Pathology of Narcolepsy
- Reduction of hypocretin II (orexin B) producing cells in posterior and lateral thalamus by 85%-95%
- reduced CSF hypocretin
Gene associated with Narcolepsy (and chromsome). Two other important notes about this mutation
Two other chromosomes seen with narcolepsy
HLA-DQB1-0602 (85% of type 1) - Chromosome 6
severity increases with more alleles
NOTE: present in 20% of general population
Mutations also seen chromosmes 4 and 21
Non-stimulant treatments for Cataplexy
Category 1 (3) Category 2 (2) Category 3 (1) Category 4 (1)
Antidepressants
- Protriptyline
- clomipramine
- nortriptyline
- fluoxetine
- sertraline
- Venlafaxine (SNRI)
Sodium oxybate (strong Gaba-B agonist) - AT NIGHT
Criteria for OSA (pediatric)
- at least one of the following:
- Snoring
- labored, obstructive, or paradoxical breathing durin gslep
- hyperactivity, cognitive troubles, or sleepiness during the day
- AND at least one obstructive or mixed apnea or hyponea during each our of sleep
- OR -
- PaCO2 is >50 mmHG for >25 % of total sleep time
- AND any of the following
- child snores
- has paradoxical thoracoabdominal motion
- flattened instpiratory nasal pressure waveform